mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |